TGFB1 and neoplasm: Furthering the intricacy of this scenario of altered immune cell recruitment towards TGF-β signaling-deficient epithelium and epithelial cancers is the observation that tumors with altered TGF-β signaling appear to have increased TGF-β ligand in their tumor-associated stroma [47–50].